To further elucidate the molecular mechanism underlying the effect of ailanthone against HCC in vivo, we performed IHC analysis to investigate the protein expression of LC3, PINK1, PRKN, BAX, and BAK1 in tumour tissues. The gene discussed is MAP1LC3A; the disease is neoplasm.